Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Protocol in Vaginal Delivery
NCT02410655Phase 4Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Nov 2015
- Primary completion
- Jul 2017
- Modality
- Peptides
01
Overview
A Phase 4 trial of oxytocin in postpartum hemorrhage (PPH), uterine atony, sponsored by NYU Langone Health. Planned start Nov 2015; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT02410655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02410655.